In the subgroup comparisons stratified by age, gender, hypertension, diabetes and hyperlipidemia, we found that both AAA and TAA patients had higher MMP9 levels in the subjects aged <65 years, either male or female, and hypertensive status compared with controls. The gene discussed is MMP9; the disease is hyperlipidemia.